Veristat will be attending Clinical Trials Europe 2019, the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.
October 8, 2019
Join Veristat at AMWA 2019 Medical Writing & Communication Conference to learn about the trends and opportunities in the field of medical writing and medical communications.
Webinar SummaryAccelerating the development of therapeutic products intended to treat serious conditions has been an interest of the public, legislators, and the scientific community for many years.
June 5, 2019
Meet Veristat at booth #1713 at the upcoming DIA Annual Meeting.
Did you miss Veristat's recent webinar on How To Ensure A Successful FDA Meeting . You can view the on-demand webinar replay and/or download the webinar presentation now by clicking on the links below:
April 23, 2019
Visit the Veristat booth #4106 at 2019 ASCO Annual Meeting taking place on May 31 - June 4, 2019.
March 11, 2019
Visit the Veristat booth #1002 at the World Orphan Drug Congress 2019 taking place from April 10-12, 2019 in National Harbor, MD.
24-26 February 2019, The Ritz-Carlton Rancho Mirage, CA
Veristat is excited to join the leading drug development executives and solution providers for a focused discussion of key new drivers shaping drug development at the Evolution Summit Spring 2019 event. At the event, Shaheen Limbada - Executive Vice President of Global Clinical Operations at Veristat – will be available to discuss the latest trends and successes in running patient-centric, cost-effective and more efficient clinical trials.
November 26, 2018
Veristat will attend the upcoming ASH Annual Meeting 2018 taking place in San Diego, California from Dec 1-4, 2018, the premier event in malignant and non-malignant hematology.
August 29, 2018
Meet Veristat at booth # 24 at OCT SoCal 2018! As a full service CRO providing impactful strategies and solutions, Veristat can meet all of your outsourcing needs to support your next clinical trial, program or regulatory submission project.